Bikash khadka | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Bikash khadka | Medicine and Dentistry | Best Researcher Award

Dr. Bikash khadka , Nepal Mediciti , Nepal

Dr. Bikash Khadka is a dedicated anesthesiologist from Lalitpur, Kathmandu, Nepal, with extensive experience in critical care and perioperative medicine. He earned his MD in Anesthesiology from Lumbini Medical College, affiliated with Kathmandu University, in 2018, after completing his MBBS at Kathmandu University School of Medical Sciences in 2012. Dr. Bikash Khadka currently serves as a Junior Consultant Anesthesiologist at Nepal Mediciti Hospital, where he manages a 32-bed mixed ICU and conducts anesthesia for various surgeries. Passionate about medical education, he has also served as a Lecturer at Lumbini Medical College. His research focuses on anesthesia techniques, critical care, and perioperative safety, with numerous published articles in peer-reviewed journals. He is proficient in advanced airway management, regional blocks, and critical patient care. Dr. Bikash  Khadka actively participates in medical workshops and conferences to stay updated in his field.

Publication Profile

Scopus

Work Experience

Dr. Bikash Khadka has been a Junior Consultant Anesthesiologist at Nepal Mediciti Hospital since August 2019, where he manages a 32-bed mixed ICU and provides anesthesia for diverse surgeries. From November 2018 to August 2019, he worked as a Lecturer at Lumbini Medical College, teaching anesthesiology to medical students. As a Resident Doctor (2015-2018) at the same institution, he performed pre-anesthetic assessments, anesthesia conduction, ICU management, and supervised junior residents. His responsibilities included emergency surgeries, obstetric analgesia, and critical care. From September 2013 to March 2014, he was a Medical Officer at Alka Hospital, providing emergency care. His experience spans specialized anesthesia services, resuscitation, and managing patients across various surgical and ICU settings.

Education and Training

Dr. Bikash Khadka earned his MD in Anesthesiology from Lumbini Medical College, affiliated with Kathmandu University, from 2015 to 2018. Prior to that, he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Kathmandu University School of Medical Sciences between 2008 and 2012. During his medical education, he acquired extensive theoretical knowledge and hands-on experience, laying the foundation for his career in anesthesiology and critical care. His education focused on pre-anesthetic assessment, anesthesia conduction, ICU management, and patient care during complex surgical procedures. Dr. Bikash Khadka also completed significant training, including ACLS, BLS, airway management, and acute care ultrasound workshops, strengthening his proficiency in both clinical and emergency care. His commitment to continual learning is reflected in his active participation in national conferences and specialized courses.

Awards and Training

Dr. Bikash Khadka has attended various prestigious conferences and workshops, including the 17th National Conference of the Society of Anesthesiologists of Nepal (SANCON) in 2016. He participated in specialized workshops like the Difficult Airway Workshop and Acute Care Ultrasound Workshop. He holds certifications in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS), showcasing his dedication to critical care excellence. His commitment to academic excellence is evident through his lecturer role and involvement in training junior residents. Dr. Bikash Khadka’s clinical expertise and research contributions have established him as a respected professional in anesthesiology and critical care in Nepal.

Research Focus

Dr. Bikash Khadka’s research focuses on anesthesiology, critical care, and perioperative management. His interests include optimizing patient outcomes in ICU settings, managing complex airway cases, and preventing anesthesia-related complications. He has contributed to research on rare medical conditions, such as Boerhaave syndrome and post-COVID-19 vaccine complications. Dr. Bikash khadka is also interested in comparative studies on pharmacological agents to improve surgical outcomes, such as using dexmedetomidine and dexamethasone for postoperative nausea prevention. His work often explores innovative approaches to regional anesthesia, patient safety, and critical care protocols. His systematic reviews and case reports provide valuable insights into anesthesia practice and patient management.

Publication Top Notes 📚

Role of pre-operative counseling with NSQIP surgical risk calculator in the surgical patients

Authors: Khadka, B., Sharma, A., Bhattarai, P.R., Rayamajhi, B., Adhikari, H.

Journal: Surgery Open Science

Year: 2024

Volume: 18, pp. 11–16

Citations: 0

Pyopericardium progressing to cardiac tamponade in a patient with dengue fever

Authors: Khadka, B., Khanal, K., Regmi, A., KC, S., Nepal, R.

Journal: IDCases

Year: 2024

Volume: 36, Article e01996

Citations: 0

Removing knotted or stuck epidural catheters: a systematic review of case reports

Authors: Khadka, B., Sharma, A., Regmi, A., Ghimire, A., Bhattarai, P.R.

Journal: Anesthesia and Pain Medicine

Year: 2023

Volume: 18(3), pp. 315–324

Citations: 1

A rare case of Boerhaave syndrome with cervico-thoracic esophageal junction rupture causing bilateral empyema; case report from Nepal

Authors: Khadka, B., Khanal, K., Dahal, P., Adhikari, H.

Journal: International Journal of Surgery Case Reports

Year: 2023

Volume: 105, Article 108018

Citations: 2

Post COVID-19 vaccine Guillain-Barré syndrome

Authors: Khadka, B., Khanal, K.

Journal: Journal of Nepal Health Research Council

Year: 2022

Volume: 19(4), pp. 852–854

Citations:

 

 

 

 

GILLES BARONE-ROCHETTE | Medicine and Dentistry | Excellence in Research

Posted on by ScienceFather

Prof. Dr. GILLES BARONE-ROCHETTE | Medicine and Dentistry | Excellence in Research

Cardiology, Grenoble Alpes University Hospital, France.

Gilles Barone-Rochette is a distinguished French cardiologist, currently a Professor of Cardiology at Grenoble Alpes University Hospital. With an extensive academic background, including an MD and PhD, he has significantly contributed to cardiovascular research and education. As the leader of multiple research units and the Competence Centre for Cardiomyopathies, his work focuses on innovative cardiovascular imaging and interventional cardiology. Additionally, Barone-Rochette has dedicated over two decades to teaching medical students and residents, shaping future cardiologists. His active involvement in prestigious medical societies and leadership roles further underscores his exceptional qualifications for the Research for Excellence in Research award.

Publication Profile :

Scopus

Academic Qualifications :

Barone-Rochette’s extensive education, from his medical studies at the University of Montpellier to multiple specialized diplomas and certifications, highlights his commitment to excellence in cardiology. His research-focused scholarship on arterial properties post-coronary syndrome underscores his dedication to innovative studies in cardiovascular health, establishing him as a well-rounded expert in the field.

Professional Experience :

Gilles Barone-Rochette has extensive professional experience in cardiology, currently serving as a Professor of Cardiology and a leading researcher at Grenoble Alpes University Hospital. Since September 2015, he has been instrumental in advancing cardiovascular care, overseeing the Cardiac Diagnostic and Interventional Unit and leading the Cardiology Research Unit. His previous role as Assistant Professor in the intensive care unit at the same hospital laid a strong foundation for his clinical expertise. With a commitment to teaching, Barone-Rochette has educated medical students and residents in cardiovascular disease and imaging, fostering the next generation of healthcare professionals.

Research Contributions :

As the leader of various research units, including the Cardiology Research Unit and the Competence Centre for Cardiomyopathies, Barone-Rochette has significantly contributed to cardiology research. His involvement in projects focused on cardiovascular imaging and interventional cardiology showcases his innovative approach and capacity for collaborative research efforts, further solidifying his status as an influential researcher.

Award And Recognition :

Gilles Barone-Rochette has been recognized for his outstanding contributions to cardiology and medical education. As a professor at Grenoble Alpes University Hospital, he has led numerous groundbreaking research initiatives in cardiovascular imaging and cardiomyopathies, earning him accolades from both national and international medical societies. His commitment to training future cardiologists has been acknowledged through multiple teaching awards, reflecting his impact on medical education. Barone-Rochette’s active involvement in prestigious organizations, including the French Society of Cardiology and the European Society of Cardiology, further highlights his dedication to advancing cardiovascular research and improving patient care in the field.

Conclusion :

Given Gilles Barone-Rochette’s exemplary qualifications, impactful research, and unwavering commitment to education, he stands out as an exceptional candidate for the Research for Excellence in Research award. His contributions to cardiology research and his leadership in training future healthcare professionals position him as a valuable asset to the medical community and a worthy recipient of this recognition.

Publication Top Notes :

  • Coronary microvascular dysfunction and atrial reservoir function 🌟 – Citations: 0 – Year: 2024
  • Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial 📊 – Citations: 4 – Year: 2024
  • Is coronary artery disease screening by imaging in patients with chronic kidney disease necessary? ❓ – Citations: 0 – Year: 2024
  • Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial 📈 – Citations: 0 – Year: 2024
  • New Method CMR-Guided Endomyocardial Biopsy in Suspicion Context of Isolated Cardiac Sarcoidosis 🧬 – Citations: 0 – Year: 2024
  • Coronary disorder is not necessarily caused exclusively by coronary microvascular dysfunction in hypertrophic cardiomyopathy 🔍 – Citations: 0 – Year: 2024
  • Myocardial Infarction with no obstructive coronary arteries: Imaging plays a central role ❤️ – Citations: 0 – Year: 2024
  • Coronary microvascular dysfunction as assessed by multimodal diagnostic imaging in patients with hypertrophic cardiomyopathy is related to the severity of cardiac dysfunction 📉 – Citations: 0 – Year: 2024
  • Segmentation of cardiac infarction in delayed-enhancement MRI using probability map and transformers-based neural networks 🖥️ – Citations: 1 – Year: 2023
  • Assessment of the Objective Effect of Virtual Reality for Preoperative Anxiety in Interventional Cardiology 🎮 – Citations: 0 – Year: 2023

Ilaria Giangrandi | Medicine and Dentistry | Women Researcher Award

Posted on by ScienceFather

Dr. Ilaria Giangrandi | Medicine and Dentistry | Women Researcher Award

Dr. Ilaria Giangrandi, AOU CAREGGI FIRENZE, Italy

 

Based on the provided information, Dr. Ilaria Giangrandi seems to be a strong candidate for the Research for Women Researcher Award. Here’s a summary of her qualifications and contributions:

Publication profile

Professional Experience

2023: Assigned as a temporary substitute for the SODs of Clinical Nutrition at AOU Careggi. Participated in developing nutritional pathways for oncology patients in the Tuscany region and revising procedures for artificial nutrition in head and neck cancer cases.

2022: Responsible for scientific oversight of a training event on basal metabolism assessment via indirect calorimetry.

2021-2022: Member of the technical committee for ESTAR, focusing on the provision of special foods and supplements.

2020-Present: Quality and Safety Coordinator for Clinical Nutrition at AOU Careggi; Facilitator for Clinical Risk since November 2021.

Education and Training

2024: Attended multiple educational events, including courses on functional medicine, deontology, and care for migrant health.

2023: Participated in various courses related to metabolic syndrome, radioprotection, and microbiota.

2022: Engaged in training programs on specialized artificial nutrition and worker safety.

Communication Skills

  • Developed strong communication skills through courses in neurolinguistic programming and extensive clinical experience in various hospital departments.

Professional Skills

  • Demonstrated expertise in multidisciplinary team work and specialized clinical practices, including roles in vascular ecocolordoppler and upper abdomen diagnostics.

Publication Top Notes

  • Effects of a chronotype-adapted diet on weight loss, cardiometabolic health, and gut microbiota: study protocol for a randomized controlled trial
    Dinu, M., Lotti, S., Pagliai, G., … Colombini, B., Sofi, F.
    Trials, 2024, 25(1), 152
    🏷️ [No citations]
  • Licorice and liver function in patients with primary liver disease: A systematic review and meta-analysis of RCTs
    Giangrandi, I., Dinu, M., Napoletano, A., … Firenzuoli, F., Sofi, F.
    Phytotherapy Research, 2024
    🏷️ [No citations]
  • Assessment of Mediterranean diet adherence and comparison with Italian dietary guidelines: a study of over 10,000 adults from 2019 to 2022
    Lotti, S., Napoletano, A., Tristan Asensi, M., … Dinu, M., Sofi, F.
    International Journal of Food Sciences and Nutrition, 2024, 75(3), pp. 336–343
    🏷️ 2 citations
  • Quality of life and nutritional status of a group of post-operative head and neck cancer patients
    Asensi, M.T., Giangrandi, I., Sartini, L., … Colombini, B., Sofi, F.
    Nutricion Hospitalaria, 2023, 40(5), pp. 919–923
    🏷️ [No citations]
  • Adherence to the Mediterranean Diet and Ultra-Processed Foods Consumption in a Group of Italian Patients with Celiac Disease
    Tristan Asensi, M., Pagliai, G., Lotti, S., … Sofi, F., Dinu, M.
    Nutrients, 2023, 15(4), 938
    🏷️ 7 citations
  • Morning chronotype is associated with higher adherence to the Mediterranean diet in a sample of Italian adults
    Lotti, S., Pagliai, G., Asensi, M.T., … Sofi, F., Dinu, M.
    Nutrition, Metabolism and Cardiovascular Diseases, 2022, 32(9), pp. 2086–2092
    🏷️ 14 citations
  • Adherence to Mediterranean diet increased during the COVID-19 lockdown in Italy: results from the web-based Medi-Lite questionnaire
    Lotti, S., Dinu, M., Pagliai, G., … Colombini, B., Sofi, F.
    International Journal of Food Sciences and Nutrition, 2022, 73(5), pp. 650–656
    🏷️ 8 citations
  • Effects of vegetarian versus Mediterranean diet on kidney function: Findings from the CARDIVEG study
    Dinu, M., Colombini, B., Pagliai, G., … Marcucci, R., Sofi, F.
    European Journal of Clinical Investigation, 2021, 51(9), e13576
    🏷️ 7 citations
  • Adherence to Mediterranean diet measured through medi‐lite score and obesity: A retrospective study
    Dinu, M., Pagliai, G., Lotti, S., … Colombini, B., Sofi, F.
    Nutrients, 2021, 13(6), 2007
    🏷️ 8 citations
  • Effect of consumption of ancient grain bread leavened with sourdough or with baker’s yeast on cardio-metabolic risk parameters: a dietary intervention trial
    Pagliai, G., Venturi, M., Dinu, M., … Sofi, F., Granchi, L.
    International Journal of Food Sciences and Nutrition, 2021, 72(3), pp. 367–374
    🏷️ 10 citations

  
Conclusion

Dr. Giangrandi’s extensive involvement in clinical nutrition, educational contributions, and leadership in quality and safety make her a highly suitable candidate for the Research for Women Researcher Award.

Rainer Pooth | Medicine and Dentistry Award | Best Innovation Award

Posted on by ScienceFather

Dr. Rainer Pooth | Medicine and Dentistry Award | Best Innovation Award

Dr. Rainer Pooth, ICAAN GmbH, Germany

Based on the information provided, Dr. Rainer Pooth appears to be a highly suitable candidate for the “Research for Best Innovation Award” in the pharmaceutical and medical industry. Here’s an assessment of his qualifications:

Publication profile

Professional Experience & Leadership

Dr. Pooth has over 20 years of experience in the global pharmaceutical and medical industry, with a strong track record of leadership in multidisciplinary teams at both global and affiliate levels. His roles as Managing Director, Global Head of Medical/Scientific Affairs, and Head of Global Clinical Development demonstrate his ability to lead and innovate in complex, highly regulated environments. His strategic input in global R&D programs, project management, and regulatory affairs underscores his expertise in driving innovation and ensuring successful product development.

Achievements & Expertise

Dr. Pooth’s achievements include multiple approvals of medicinal products and medical devices across key global markets such as the EU, US, Australia, and Asia. He holds more than 35 patents, with a significant portion becoming commercially relevant, highlighting his innovative contributions to the field. His extensive publication record, including over 50 publications in international journals and books, as well as his role as an invited speaker at major scientific congresses, further cements his reputation as a leader in pharmaceutical research and innovation.

Global Impact & Collaboration

Dr. Pooth’s global network of experts and key opinion leaders, along with his experience in managing international submission teams and regulatory interactions, illustrates his ability to navigate and influence the global pharmaceutical landscape. His leadership in directing high-level global teams and managing collaborations with regulatory authorities and contract research organizations (CROs) demonstrates his capability to bring innovative products to market successfully.

Publication Top Notes

  • “Treatment of Refractory Cardiac Arrest by Controlled Reperfusion of the Whole Body” – A study exploring CARL in a multicenter setting, highlighting its impact on refractory cardiac arrest patients (2023).
  • “The Impact of Head Position on Neurological and Histopathological Outcome Following CARL” – Investigates how head positioning affects outcomes in a pig model during CARL (2023).
  • “Extracorporeal Cardiopulmonary Resuscitation—Evidence and Implications” – Discusses ECPR’s evidence base and its clinical implications (2023).
  • “Effects of Prolonged Serum Calcium Suppression during ECPR in Pigs” – Examines the effects of serum calcium suppression during ECPR, showing implications for treatment strategies (2023).
  • “Limiting Calcium Overload after Cardiac Arrest” – Focuses on the role of albumin in reducing calcium overload during CARL (2023).
  • “Pervasive Platelet Secretion Defects in SARS-CoV-2 Patients” – Analyzes platelet defects in COVID-19 patients and their potential implications for treatment (2023).
  • “CARL – Controlled Reperfusion of the Whole Body” – A book detailing the CARL procedure, providing a comprehensive resource for clinicians (2022).
  • “Observational Study on Implications of the COVID-19-Pandemic for Cardiopulmonary Resuscitation” – Examines the pandemic’s impact on resuscitation practices, offering valuable insights (2022).
  • “Monitoring Mitochondrial Partial Oxygen Pressure During Cardiac Arrest and ECPR” – A pilot study exploring mitochondrial oxygen monitoring during cardiac arrest in a pig model (2021).
  • “Brain Vulnerability and Viability after Ischaemia” – A review on the neurological outcomes following ischemic events, highlighting vulnerabilities and potential treatment avenues (2021).

Conclusion

Dr. Pooth’s extensive experience, significant contributions to the development and approval of innovative pharmaceutical products, and his leadership in global research and development make him a strong candidate for the “Research for Best Innovation Award.” His work has had a substantial impact on multiple therapeutic areas, including dermatology, immunology, aesthetic medicine, oncology, and neurology, making him well-deserving of recognition in this prestigious category.